Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MAKS Pharmaceuticals is an Indian pharmaceutical company specializing in the development, manufacturing, and export of a diverse range of generic pharmaceutical formulations. The company's portfolio includes key therapeutic areas such as anti-infectives, cardiovascular medicine, gastroenterology, and pain management. MAKS Pharmaceuticals operates manufacturing facilities that comply with WHO-GMP standards, ensuring the delivery of high-quality and cost-effective healthcare products. The company has established a significant presence in international markets, particularly across Africa, Southeast Asia, and the CIS region. By focusing on robust formulation development and regulatory compliance, MAKS Pharmaceuticals aims to improve global access to essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MAKS Pharmaceuticals.